Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medical Marijuana, Inc. Subsidiary HempMeds® Launches New 50mg Active Relief Roll-On Product at 2018 Cannabis World Congress Los Angeles

MJNA

PR Newswire

SAN DIEGO, Sept. 27, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, subsidiary HempMeds® announced today that it will release a new topical hemp product, its 50mg Active Relief Roll-On, at the Cannabis World Congress & Business Exposition (CWCBE) in Los Angeles, CA.

"After experiencing tremendous success with our 10mg Active Relief Roll-On, we are thrilled to announce the release of a new version of this topical hemp product now with 50mg of cannabidiol (CBD), designed to better help athletes and active adults recover from muscle fatigue," said HempMeds® President Todd Morrow. "HempMeds is committed to creating sustainable, natural and trustworthy products and we are confident our expanding customer base will enjoy this new product."

The Cannabis World Congress & Business Expo, which takes place September 27-29 at the Los Angeles Convention Center, is the leading forum for dispensary owners, growers, suppliers, investors, medical professionals, government regulators, legal counsel, and entrepreneurs looking to achieve business success and identify new areas of growth in this dynamic and fast-growing industry.

This new formulation of the HempMeds® Active Relief Roll-On is formulated with natural herbal extracts, menthol and 50 mg of hemp extract. It features a quick-dry formula and a light menthol scent. HempMeds® Active Relief Roll-On cooling effects help to soothe tired, overworked muscles and address the joint stiffness and discomfort that come with everyday exertion.

"The company is excited to release its newest topical hemp product at one of the biggest industry events of the year," said Medical Marijuana, Inc. Chief Executive Officer Dr. Stuart Titus. "It's incredible to have a platform like this to be able to release a product that we hope will help customers find comfort and make the most out of life."

If you would like to learn more at CWCBExpo, visit HempMeds® at booth #106 and contact Nathaniel@cmwmedia.com to schedule an on-site product demo with HempMeds® Spokesperson and UFC fighter Liz Carmouche.

Learn more about HempMeds® Active Relief Roll-On and other exciting CBD hemp oil products at HempMeds.com.

About HempMeds®
HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC: MJNA) and the Company's exclusive master distributor and contracted marketing company, handling sales and distribution.

About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.

To see Medical Marijuana, Inc.'s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.'s shop.

FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

LEGAL DISCLOSURE
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

CONTACT:

Public Relations Contact:
Andrew Hard
Chief Executive Officer, CMW Media
P. 858-264-6600
andrew.hard@cmwmedia.com 
www.cmwmedia.com 

 

Cision View original content:http://www.prnewswire.com/news-releases/medical-marijuana-inc-subsidiary-hempmeds-launches-new-50mg-active-relief-roll-on-product-at-2018-cannabis-world-congress-los-angeles-300720066.html

SOURCE Medical Marijuana, Inc.